1. Home
  2. CMPS

as of 12-10-2025 4:00pm EST

$6.69
+$0.33
+5.19%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Chart Type:
Time Range:
Founded: 2020 Country:
United Kingdom
United Kingdom
Employees: N/A City: CHESIRE
Market Cap: 598.7M IPO Year: 2020
Target Price: $16.43 AVG Volume (30 days): 1.5M
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.74 EPS Growth: N/A
52 Week Low/High: $2.25 - $7.08 Next Earning Date: 11-04-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered CMPS Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 75.66%
75.66%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest COMPASS Pathways Plc American Depository Shares News

CMPS Breaking Stock News: Dive into CMPS Ticker-Specific Updates for Smart Investing

All CMPS News

Share on Social Networks: